INVEA THERAPEUTICS, INC

Profile

Company Names

INVEA THERAPEUTICS, INC

Addresses

2614 BOSTON POST ROAD, SUITE 33B, GUILFORD, CT 06437

2614 BOSTON POST ROAD, SUITE #33AR, GUILFORD, CT 06437

Phone Numbers

203-643-8002
203-204-6363

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$1,945,244.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-10-31 
$120,250.00 
$120,250.00 
$0.00 
Equity 
2
2025-03-31 
$300,000.00 
$600,000.00 
$300,000.00 
Debt 
1
2022-04-07 
$1,524,994.00 
$5,760,000.00 
$4,235,006.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
AIELLO 
EXECUTIVE OFFICER
SPRING BANCORP INC   |  INVEA THERAPEUTICS, INC   |  POLYGRAF INC.
MICHAEL 
J. 
AIELLO 
EXECUTIVE OFFICER
INVEA THERAPEUTICS, INC
SALVATORE 
 
ALESCI 
EXECUTIVE OFFICER
INVEA THERAPEUTICS, INC
KERRIE 
 
BRADY 
DIRECTOR
ARCION THEREAPEUTICS INC   |  ARCION THERAPEUTICS, INC.   |  SCIFLUOR LIFE SCIENCES, INC.   |  OCUTERRA THERAPEUTICS, INC.   |  INVEA THERAPEUTICS, INC
STEPHEN 
 
DOBERSTEIN 
DIRECTOR
FORTE BIOSCIENCES, INC.   |  INVEA THERAPEUTICS, INC
AMAN 
 
KANT 
EXECUTIVE OFFICER
INVEA THERAPEUTICS, INC
DEMETRIOS 
 
KYDONIEUS 
DIRECTOR
INVEA THERAPEUTICS, INC
SANDEEP 
 
LAUMAS 
DIRECTOR
BEARING CIRCLE MILLENIUM FUND, LP   |  GLOBAVIR BIOSCIENCES INC.   |  INNOVATE BIOPHARMACEUTICALS INC.   |  BEARING CIRCLE MILLENNIUM FUND LP   |  INNOVATE BIOPHARMACEUTICALS, INC.   |  IB PHARMACEUTICALS INC.   |  UNICYCIVE THERAPEUTICS, INC.   |  9 METERS BIOPHARMA, INC.   |  INSTIL BIO, INC.   |  INVEA THERAPEUTICS, INC
VIMAL 
 
MEHTA 
DIRECTOR
INVEA THERAPEUTICS, INC
KRISHNAN 
 
NANDABALAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
INVEA THERAPEUTICS, INC
SHUNICHIRO "STEVE" 
 
OKADA 
EXECUTIVE OFFICER
INVEA THERAPEUTICS, INC
JONATHAN 
 
ZALEVSKY 
DIRECTOR
INVEA THERAPEUTICS, INC   |  REALTA LIFE SCIENCES, INC.   |  NEKTAR THERAPEUTICS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-10-31 
2025-04-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-03-31 
2022-04-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#